Literature DB >> 28254567

Complexity in cancer stem cells and tumor evolution: Toward precision medicine.

Caterina A M La Porta1, Stefano Zapperi2.   

Abstract

In this review, we discuss recent advances on the plasticity of cancer stem cells and highlight their relevance to understand the metastatic process and to guide therapeutic interventions. Recent results suggest that the strict hierarchical structure of cancer cell populations advocated by the cancer stem cell model must be reconsidered since the depletion of cancer stem cells leads the other tumor cells to switch back into the cancer stem cell phenotype. This plasticity has important implications for metastasis since migrating cells do not need to be cancer stem cells in order to seed a metastasis. We also discuss the important role of the immune system and the microenvironment in modulating phenotypic switching and suggest possible avenues to exploit our understanding of this process to develop an effective strategy for precision medicine.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer stem cells; Metastasis; Phenotypic switching; Precision medicine

Mesh:

Year:  2017        PMID: 28254567     DOI: 10.1016/j.semcancer.2017.02.007

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  8 in total

1.  Stem cells, immortality, and the evolution of metastatic properties in breast cancer: telomere maintenance mechanisms and metastatic evolution.

Authors:  Nathaniel J Robinson; Derek J Taylor; William P Schiemann
Journal:  J Cancer Metastasis Treat       Date:  2019-05-06

Review 2.  How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance.

Authors:  Valerio Ciccone; Lucia Morbidelli; Marina Ziche; Sandra Donnini
Journal:  Cancer Drug Resist       Date:  2020-03-19

Review 3.  The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer.

Authors:  Dimakatso Alice Senthebane; Arielle Rowe; Nicholas Ekow Thomford; Hendrina Shipanga; Daniella Munro; Mohammad A M Al Mazeedi; Hashim A M Almazyadi; Karlien Kallmeyer; Collet Dandara; Michael S Pepper; M Iqbal Parker; Kevin Dzobo
Journal:  Int J Mol Sci       Date:  2017-07-21       Impact factor: 5.923

Review 4.  Immune precision medicine for cancer: a novel insight based on the efficiency of immune effector cells.

Authors:  Jean-François Rossi; Patrice Céballos; Zhao-Yang Lu
Journal:  Cancer Commun (Lond)       Date:  2019-06-14

Review 5.  Modulation of Immune Components on Stem Cell and Dormancy in Cancer.

Authors:  Xiaofan Jiang; Lu Liang; Guanglei Chen; Caigang Liu
Journal:  Cells       Date:  2021-10-21       Impact factor: 6.600

Review 6.  Mini-Review: Can the Metastatic Cascade Be Inhibited by Targeting CD147/EMMPRIN to Prevent Tumor Recurrence?

Authors:  Michal A Rahat
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

Review 7.  Targeting TGF-β signal transduction for fibrosis and cancer therapy.

Authors:  Dandan Peng; Minyang Fu; Manni Wang; Yuquan Wei; Xiawei Wei
Journal:  Mol Cancer       Date:  2022-04-23       Impact factor: 41.444

8.  Highly expressed STAT1 contributes to the suppression of stemness properties in human paclitaxel-resistant ovarian cancer cells.

Authors:  Fanchen Wang; Lingyun Zhang; Jiao Liu; Jinguo Zhang; Guoxiong Xu
Journal:  Aging (Albany NY)       Date:  2020-06-09       Impact factor: 5.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.